Composition

US7335650B2 · kind B2 · utility

Assignees

• Sterix Limited · GB
• SCHERING CORPORATION · US

Inventors

• Barry Victor Lloyd Potter · Slough, GB
• Michael John Reed · London, GB
• Walter Elger · Berlin, DE
• Gudrun Roddersen · Jena, DE
• Heinrich-Thomas Proske · Berlin, DE

Key dates

• Filing date: Apr 10, 2002
• Grant date: Feb 26, 2008
• Expiry date: Apr 25, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/567
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

There is provided a pharmaceutical composition comprising (i) a compound of the formulawherein: X is a hydrocarbyl ring having at least 4 atoms in the ring; K is a hydrocarbyl group; Rs is a sulphamate group; (ii) optionally admixed with a pharmaceutically acceptable carrier, diluent, excipient or adjuvant, wherein the compound is present in an amount to provide a dosage of no greater than 200 μg/day.